(Q77291893)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

E P Havranek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

I Thomas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

W B Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

G A Ponce

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M Bilsker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M A Munger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R A Wolf

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

1174-1181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

Losartan in heart failure: preclinical experiences and initial clinical outcomes

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

Functional and biochemical analysis of angiotensin II-forming pathways in the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

Correlates and prognostic implication of exercise capacity in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900695-0

7 January 2021

10.1016/S0735-1097(98)00695-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10193713%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference